Conclusions  by Jacoby, Ann & Baker, Gus A.
Seizure 19 (2010) 690–691Editorial
Conclusions
As the account by Temkin makes abundantly clear, epilepsy is
not a static entity–time and place matter. If basic science, clinical
and social developments occur as rapidly over the next 60 years as
over the last, the epilepsy landscape will likely be a very different
one by the year 2070.We asked our contributors not only to reﬂect
back over the last 60 years, but also to think forward and speculate
on how things might be by the time Epilepsy Action reaches its
120th birthday! How might the ‘gaze’ on epilepsy change? As the
articles by John Jeffreys, Mark Rees and Sarah Wilson and Jerome
Engel highlight, in 2010 we are able to see the brain as never
before, opening up huge possibilities for management of seizures
and epilepsy in the future. Yet despite such profoundly important
developments, Mark Rees reminds us that research has so far failed
to uncover a common epilepsy gene; andMartin Brodie that choice
of drug treatment remains largely a matter of guesswork and we
still have a long way to go to achieve truly rational management.
Financial, as well as scientiﬁc, limitations mean, as highlighted by
Bert Aldenkamp and Helen Cross, that there is and will likely
continue to be a lack of choice for patients over provision of their
care and the nature of their treatment options; and as Hanneke de
Boer and Philip Lee amply illustrate, misinformation and
misrepresentation of what epilepsy is and is not continues to
limit the lives and opportunities of people with epilepsy in ways
that are both unnecessary and unacceptable. Not surprising, then,
that the ‘wish lists’ for the future set out by Madelin Bexon and
Steven Schachter are quite lengthy ones!
New knowledge demands new strategies. In a recently
published and highly erudite article, Milton1 observes that there
 A recently trialled keyhole surgical approach for treatment of
medically intractable TLE, with no reduction in rates of seizure
freedom and reduced operative time and earlier hospital
discharge for those patients in the keyhole treated group, when
compared to patients operated on using traditional resection
methods3;
 Developments in drugs, devices and delivery systems (the three
‘D’s) thatwill allow the tracking of seizure generation in epileptic
networks and the triggering of drug delivery at seizure foci to
prevent epileptic attacks or clinical events4;
 A critical future role for neuropsychology in establishing epilepsy
phenotypes, genetic disease risks and possible predictors of
treatment outcomes; and in characterising disease severity and
functional impairments associated with new and evolving
measures of brain structure and function5;
 The continuing critical unravelling of the relationship between
epilepsy and psychological comorbidities6 with clear implica-
tions for future provision of comprehensive and effective clinical
care to address them7;
 New approaches to seizure control, for example, use of slow
breathing exercises as a means of increasing parasympathetic
tone and so, potentially, altering cortical activity and seizure
thresholds in people with refractory epilepsy8;
 The potential use of computer-assisted telephone interviewing
to diagnose seizures and epilepsy in the large samples of patients
required for reproduceable clinical and epidemiological studies9;
 Methods for ensuring that new research knowledge on epilepsy
effectively translates into clinical practice, and into real beneﬁts
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gists, on the one side, and computational neuroscientists, on the
other’, inwhich both sides – and, ultimately, peoplewith epilepsy –
lose. Milton argues that it is now possible to use mathematical
modelling to propose experimentally testable predictions about
what is ‘fundamentally a dynamic disease’; and concludes that
new and more effective treatment strategies will most likely be
realised when clinicians and modellers come together in interdis-
ciplinary teams. Commenting, Osorio2 concludes that Milton’s
approach offers the possibility of insights into epilepsy that have so
far eluded traditional clinical methods. As non-mathematicians
and non-epileptologists, we make no claim to fully appreciate or
critique the arguments Milton sets out, only to note the exciting
possibilities he – like several of our authors – offers for how
radically our understanding of epilepsy may change over the next
60 years.
And it is not only over understanding of the ‘epileptic’ state that
new possibilities are offered to us. A rapid review of recent
publications on epilepsy identiﬁed as current developments and
likely innovations to treatment and epilepsy care:1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2010.10.025for patients ;
 The internet and social networking sites as a powerful means of
altering public perceptions of epilepsy for the better and helping
to dispel the stigma.11
All these innovations seem to promise a brave new world,
indeed, for epilepsy over the next six decades! It has even been
suggested that as we acquire greater understanding of the
aetiologies of seizures, the nomenclature will shift, so that people
who have seizures will no longer be referred to generically as
‘having epilepsy’, but individually as experiencing a speciﬁc
syndromic disorder or condition. What impact such ‘re-framing’12
might have for the psychosocial – particularly the stigma – status
of those concerned is difﬁcult to know, but surely offers interesting
food for thought.
We want to close this piece by, ﬁrst of all, thanking all our
contributors for rising so magniﬁcently to the challenge we set
them––our contributors with epilepsy for their honest, sometimes
painful and always thoughtful reﬂections on their own lives with
epilepsy; and our academic contributors for making accessible tovier Ltd. All rights reserved.
Editorial / Seizure 19 (2010) 690–691 691non-experts the highly complex topics they have covered and
challenging some currently received wisdoms. We are truly
appreciative of the time, energy and enthusiasm they have all
shown for this project. The result is, we believe, a remarkable
tribute to Epilepsy Action.
As noted earlier in this special edition, Seizure was originally
established as the ofﬁcial academic journal of Epilepsy Action –
then The British Epilepsy Association – under the worthy
stewardship of Dr. Tim Betts, a name many readers will be
familiar with and someone who himself contributed enormously
to improving the care of people with epilepsy. Seizure remains one
of the major journals in the ﬁeld, its continuing success safe-
guarded by the current editorship, Professors Bert Aldenkamp and
Paul Boon. We also want to thank them for their support of our
ideas as to how this special edition should be realised.
Finally, thoughwe almost certainly won’t be around in 60 years
time, we are fairly conﬁdent that Epilepsy Action will be. Over the
last 60 years, Epilepsy Action has, amongst many other things,
been instrumental in bringing about changes to the UK legal
framework relating to epilepsy, led in the creation of an All-Party
Parliamentary Group on Epilepsy, launched the Sapphire Nurse
scheme, campaigned successfully against generic substitution of
branded antiepileptic medications, and contributed to the
development of the UK National Institute for Clinical Excellence
(NICE) Guidelines for the management of epilepsy. Over the period
of its existence, EA’smembership has grown almost a hundred-fold
and demand for its information and advice service has also
increased exponentially. Last year, the EA website received around
three-quarters of amillion hits. Echoing Jayne Cage’s sentiments in
the ﬁrst article in this special edition, it is clear that EA means a
great deal to a greatmany people not just in theUK, butworldwide.
Whatever developments take place in the very wide ﬁeld of
epilepsy, we suspect that in 60 years from now there will still be a
need for organisations that provide information and support and
champion the needs of people with seizure disorders, whatever
their origin and cause, and under whatever diagnostic label they
ﬁnd themselves. So we want to end by offering our very best
wishes today and for the future to Epilepsy Action and all who are
associated with it – A VERY HAPPY 60th BIRTHDAY!Conﬂict of interest statement
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